Search
for
Sort by
Research 91–120 of 108
- Drug-Induced Hair Changes
- Chemotherapy and Cutaneous Drug Reactions
- Past, Present, and Future of Plant-Derived Extracellular Vesicles in Biomedical Applications
- Advancements in Therapeutic Deep Eutectic Solvents as Multifunctional Transdermal Delivery Systems
- Self-Assembled Berberine-Sinapic Acid Nanomedicine for Synergistic Chemotherapy
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Anlotinib or Bevacizumab Combined with Taxane/Capecitabine for the Second-Line or Subsequent Treatment of HER-2 Negative Metastatic Breast Cancer: A Retrospective Cohort Study
- Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- Unique Circulating MicroRNA Signatures Distinguish Severe Alopecia Areata from Other Inflammatory Skin Diseases
- Drug-associated gingival disorders: a retrospective pharmacovigilance assessment using disproportionality analysis
- Ponatinib-induced pityriasis rubra pilaris-like adnexal dysmaturation: A case report
- The possibilities of correction of premature greying of hair and involutive hair changes
- Gastric cancer; actualities and perspectives of early diagnosis and targeted therapy
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Mucocutaneous Side Effects of Antineoplastic Drugs Used in Cancer Therapy in Erbil
- Transcriptome-guided development of a fibrosis-reversal compound reduces skin scarring and allows regeneration via mitochondrial uncoupling
- Unusual progression of renal cell carcinoma with carcinomatosis peritoneii and Krukenberg tumour and alopecia with sunitinib therapy in young female
- Management of Older Patients With Metastatic Renal Cell Carcinoma Receiving Sunitinib: A Hypothetical, Illustrative Case Scenario
- Sunitinib
- 710 BIOMARKERS OF SUNITNIB CLINICAL RESPONSE IN METASTATIC RENAL CLEAR CELL CARCINOMA PATIENTS
- Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Hair Depigmentation Is a Biological Readout for Pharmacological Inhibition of KIT in Mice and Humans
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- KRDQN: An Interpretable Prediction Framework for Adverse Drug Reactions via Knowledge–Graph Reinforced Deep Q-Learning
- Effets secondaires cutanéo-muqueux des nouvelles molécules anticancéreuses: Inhibiteurs de l'EGF-R, inhibiteurs de tyrosine kinase et stabilisateurs du fuseau mitotique
- Tombo em João Pessoa dá força a Memorial da Arquitetura Paraibana